Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Arthritis, Rheumatoid 5Colitis, Ulcerative 2Recurrence 1Lymphoma 1Inflammatory Bowel Diseases 1Crohn Disease 1

Interventions

Infliximab 3Tea 2Polyethylene Glycols 2Lidocaine 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2sodium phosphate 1purine 1prucalopride 1picosulfate sodium 1golimumab 1fumaric acid 1Sulfasalazine 1Pneumococcal Vaccines 1Passive Cutaneous Anaphylaxis 1Papillomavirus Vaccines 1Narrow Band Imaging 1Morphine 1Methotrexate 1Mesalamine 1Mercaptopurine 1MEDI2070 1Exercise 1Etanercept 1Dietary Supplements 1Diatrizoate Meglumine 1Diagnostic Imaging 1Calcium Dobesilate 1CT-P13 1Bupivacaine 1Bisacodyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Inflammatory Bowel Diseases × golimumab × Clear all
NCT01804166 2025-02-04

A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)

Janssen Scientific Affairs, LLC

Phase 4 Completed
1 enrolled 1 chart
Lymphoid

Colitis, Ulcerative, Crohn Disease, Lymphoma, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡